The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
105966715 10596671 5 F 20140903 20160912 20141120 20160919 EXP GB-OTSUKA-EU-2014-10571 OTSUKA 22.00 YR M Y 44.45000 KG 20160919 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
105966715 10596671 1 PS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular UNK D 202971 SUSPENSION FOR INJECTION
105966715 10596671 2 SS ABILIFY MAINTENA ARIPIPRAZOLE 1 Parenteral UNK D 202971 SUSPENSION FOR INJECTION
105966715 10596671 3 SS ABILIFY ARIPIPRAZOLE 1 Oral 20 MG, UNK U 0 20 MG TABLET
105966715 10596671 4 SS ABILIFY ARIPIPRAZOLE 1 U 0 TABLET
105966715 10596671 5 SS ZOPICLONE ZOPICLONE 1 Oral 7.5 MG, UNK U 0 7.5 MG
105966715 10596671 6 C LORAZEPAM. LORAZEPAM 1 Unknown 2.5 MG, UNK 0 2.5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
105966715 10596671 1 Patient restraint
105966715 10596671 2 Psychotic disorder
105966715 10596671 3 Patient restraint
105966715 10596671 4 Psychotic disorder
105966715 10596671 5 Insomnia
105966715 10596671 6 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
105966715 10596671 LT
105966715 10596671 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
105966715 10596671 Abdominal pain
105966715 10596671 Abnormal weight gain
105966715 10596671 Agitation
105966715 10596671 Angina pectoris
105966715 10596671 Anxiety
105966715 10596671 Asthenia
105966715 10596671 Back pain
105966715 10596671 Body temperature abnormal
105966715 10596671 Chest pain
105966715 10596671 Cold-stimulus headache
105966715 10596671 Decreased appetite
105966715 10596671 Discomfort
105966715 10596671 Dizziness
105966715 10596671 Dry mouth
105966715 10596671 General physical condition abnormal
105966715 10596671 Headache
105966715 10596671 Heart rate increased
105966715 10596671 Heart rate irregular
105966715 10596671 Hyperhidrosis
105966715 10596671 Injection site pain
105966715 10596671 Insomnia
105966715 10596671 Limb discomfort
105966715 10596671 Liver disorder
105966715 10596671 Liver injury
105966715 10596671 Muscle spasms
105966715 10596671 Musculoskeletal stiffness
105966715 10596671 Myalgia
105966715 10596671 Nausea
105966715 10596671 Off label use
105966715 10596671 Overdose
105966715 10596671 Palpitations
105966715 10596671 Photopsia
105966715 10596671 Restlessness
105966715 10596671 Somnolence
105966715 10596671 Suicidal ideation
105966715 10596671 Tremor
105966715 10596671 Vision blurred

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
105966715 10596671 1 20140903 20140903 0
105966715 10596671 2 20140903 20141016 0
105966715 10596671 3 20140905 0